J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of <i>Pseudomonas</i> Exotoxin A. [PDF]
Pincus SH +8 more
europepmc +1 more source
177Lu-Labeled Antibody-Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors. [PDF]
Yamaguchi A +9 more
europepmc +1 more source
Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges. [PDF]
Ren S, Pan F, Jin J.
europepmc +1 more source
Pembrolizumab combined with disitamab vedotin in human epidermal growth factor receptor 2-positive metastatic colorectal cancer. [PDF]
Xu X +12 more
europepmc +1 more source
Old methods, lasting impact in relapsed/refractory primary mediastinal B-cell lymphoma. [PDF]
Ringelstein-Harlev S.
europepmc +1 more source
Efficacy and Safety of Datopotamab Deruxtecan From a Single-Institution Experience in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer After Multiple Prior Therapies Including Antibody-Drug Conjugates. [PDF]
Shimada H +18 more
europepmc +1 more source
In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy. [PDF]
Allen KJH +7 more
europepmc +1 more source
Profiling EGFR, c-MET, and B7H3 co-expression to guide next-generation dual-drug conjugate strategies in colorectal cancer. [PDF]
Yang Y +12 more
europepmc +1 more source
Real-world patient-reported outcome comparing antibody-drug conjugates and conventional chemotherapy in metastatic breast cancer. [PDF]
Milani M +10 more
europepmc +1 more source
Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugate. [PDF]
Pincus SH +9 more
europepmc +1 more source

